CA15-3, a soluble fragment of MUC1 typically used as a serum biomarker for breast cancer, displays substantial amounts of TACAs such as sialyl-Lewis antigens, sialyl-Tn, Tn, sialyl-T, and T [68,69,70,71]. Here, MUC1 is linked to breast carcinoma.